The aim of this study was to assess the effectivity of thalidone group, one with side effects and another after a myocardial infarction. Although blood pressure (BP) dietary measures in the treatment of hypertension. Therefore, a single-blind randomised clinical trial was in the diet group decreased less than in the drug group, of the patients in the diet group 45% fell back to a norcarried out in elderly persons with recently diagnosed hypertension. Patients were recruited from a general mal systolic and 50% to a normal diastolic BP (drug treatment group, systolic 75% and diastolic 85%). In practice (6555 persons) during visits or after written invitation or invitation by phone. New hypertensive contrast with the diet group, lipid spectrum and blood glucose concentration in the diuretic group, however, patients (with measurements taken on three different occasions Ͼ159 mm Hg systolic and/or Ͼ Ͼ Ͼ94 mm Hg deteriorated slightly.
Introduction disease (CHD), and a 22% fall in mortality from The treatment of mild to moderate hypertension CVA. These percentages are higher than the estiwith drugs is usually highly effective in healthy eldmated effect of drug treatment (mortality reductions erly individuals. 1 Indeed, the effects in terms of 5-of 9 and 15%, respectively). So far, research has year morbidity and mortality are better in older than shown that dietary advice aimed at lowering sodium in younger people. Antihypertensive drugs, howintake, enriching potassium intake, and reducing ever, may have an ontoward effect on glucose and body weight effectively reduces BP in middle-aged fat metabolism. 2, 3 Dietary measures aimed at reducpeople. ing blood pressure (BP) reduction lack these drawThe question whether these measures are applibacks. However, they are less effective because they cable to elderly persons has been little studied. For have more far reaching consequences for patients ' everyday practice we need to know how the effects daily lives.
on BP relate to those of standard drug treatments in So which clinical approach should be used? If elderly hypertensive patients. Therefore, we set out dietary control of BP proved as effective as drug conto study the following questions: trol, we could expect these measures to reduce patients' morbidity and mortality more effectively.
( 
Subjects and methods
30% success rate (% normotensives) between the Design diet group and the drug group, alpha of 5% and beta of 30%, a total sample of 38 patients is sufficient. After informed consent, eligible persons particiBecause adherence to dietary measures is more difpated in a single-blind, randomised, controlled trial ficult than adherence to drugs, the success rate in with a baseline measurement and three follow-up group B is expected to be higher. If the difference measurements each month during a 3-month period does not exceed 30%, this is considered to be in (Figure 1 ). Inclusion took place during 12 months.
favour of dietary measures, having some other All participants were referred to the dietician for an beneficial effect as well. analysis of their customary dietary pattern. They were then randomly assigned to one of two groups by a dietician: the intervention group (A) with the Intervention and control treatment diet and the control group (B) with the usual medication (ie, chlorthalidone). After allocation the dietiPatients assigned to group A received a diet based cian prescribed either the diet or the drugs, thereby on their dietary habits which met the following arriving at blindness of the general practitioner and specifications: sodium Ͻ100 mmol/24h (approxihis practice nurse for treatment.
mately 6 g of table salt), potassium Ͼ75 mmol/24h, and a sodium/potassium ratio Ͻ1. Where appropriate, this advice was adjusted on the basis of Patient selection nutritional-anamnestic data during the monthly folPatients were recruited from the computerised files low-up visits. The dietician collected data on indiof a general practice (6555 persons). Subjects were vidual food intake by means of a 7-day food diary. eligible if they were between 60 and 80 years of age, Two weeks prior to the first visit with the dietician, previously unknown with hypertension, with a diaseach person received a letter with the request to tolic BP (DBP) of 95-110 mm Hg and/or a systolic write down all food and drink taken in a diary. They BP (SBP) of 160-220 mm Hg, and if they had no were also asked to write down the manner of prepcontra-indications for antihypertensive drug treataration and the brands of the food stuffs used. Durment. Patients were initially recruited by case-finding each visit the terms 'dish', 'plate' and 'glass' ing during occasional consultations. Those who did were used to estimate the quantities taken of each not consult their general practitioner were invited food stuff. Intake data were coded for computer to visit the practice for the measurement of their BP.
analysis and used for calculation of sodium, potassPatients with impaired renal function, CHD, congesium and energy intake. In this way the compliance tive heart failure, diabetes mellitus, dementia, menwith the dietary measures could be stimulated on tal disturbances, carcinoma or severe disability were four occasions. In case of overweight (body mass excluded. Of all persons aged 60-80 years who index (BMI) Ͼ25), a low-energy diet was prescribed underwent a BP measurement (n = 531) 61 appeared for the diet group. This was the case in 13 of the 20 to have a previously unknown mild hypertension.
patients. Patients assigned to the drug group were The diagnosis of mild hypertension was based on prescribed chlorthalidone 25 mg once a day by the six systolic and diastolic readings (two on three difdietician. In this way the general practitioner and ferent occasions with an interval of at least 2 weeks).
his practice nurse were blinded for treatment. Patients with three readings of 95-110 mm Hg diasPatients of group B received a low profile standard tolic and/or 160-220 mm Hg systolic were asked for advice for their diet. They also visited the dietician consent to participate. After informed consent 42 each month for compliance with the prescribed regipatients were prepared to participate in the trial. If men. In this way a relevant contrast between the diet during the follow-up consultations patients showed and the drug group was strived for, giving as much up with a DBP exceeding 110 mm Hg diastolic attention to group A as to group B. and/or 240 mm Hg systolic and these values were measured by two repeated measurements, patients were unblinded and treated in conformity with the Measurements guidelines of the Dutch College of General PracBlood pressure: The practice nurse who was unaware of the allocation of the patients carried out all BP measurements after specific training in measurement techniques. BP measurement was carried out with a recently calibrated mercury manometer fitted with a standard cuff (inner-cuff 12 × 35) after 5 min of rest in the sitting position with the cuff at heart level and without tight clothing. Drop rate of mercury column: 2 mm/sec. During each monthly follow-up session two measurements were performed. The diastolic value was read at phase 5 of the Korotkov sounds, to the nearest 2 mm Hg, with the eyes at the top level of the mercury column. As follow-up values the mean of the two Figure 1 The study protocol.
measurements were used. This procedure was car- urine. These variables were used for the measurement of adherence to the diet of patients of group A, and for patients of group B to control for possible analysis. Table 1 shows the baseline values of the dietary changes following the detection of a preremaining 40 persons. With the exception of body viously unknown mild hypertension. In this way a weight (76 vs 73) and 24-h urinary sodium excretion change in both variables for all patients could be (125 vs 114), we did not detect any major interestablished. Creatinine excretion in 24-h urine was group differences. In any case, none of these differdetermined at baseline and after 3 months to control ences was statistically significant. for completeness of the 24-h urine collection.
The effectiveness of dietary measures Side effects
During the run-in period (4, 2 and 0 weeks before The practice-nurse took blood samples for the deterrandomisation) mean SBP values were 167(16), mination of total cholesterol, HDL-cholesterol and 167(18) and 166(15) mm Hg, respectively, and mean triglycerides concentration, from all patients in a DBP values were 99(8), 97(7) and 97(7) mm Hg, fasting state at baseline and after 3 months. Blood respectively. Only the decrease of mean DBP of 2 glucose and serum potassium were determined in mm Hg after the first 2 weeks was statistically sigthe same blood samples.
nificant (P = 0.04). Table 2 shows the mean BP during treatment at Statistical analysis different follow-up moments of the study. After 3 months SBP was reduced by 8(8) mm Hg (P = 0.00) Within-group differences between baseline and end in the diet and by 16(20) mm Hg (P = 0.00) in the values for continuous variables were tested by Studdrug group. For DBP these values were 4(7) mm Hg ent's t-test for paired groups. Changes over time (P = 0.00) and 9(7) mm Hg (P = 0.00), respectively. were tested between both groups by unpaired StudAfter 3 months the mean systolic ambulatory BP was ent's t-test on changes between baseline and reduced by 6(10) mm Hg (P = 0.01) in the diet, and measurements at 3 months, as proportions of baseby 13(16) mm Hg (P = 0.00) in the drug group (data line values. Pearson correlation coefficients for linnot shown in Table 2 ). For diastolic ambulatory BP ear relations were calculated in each group with these values were 4(6) mm Hg (P = 0.03) and 7(9) change over time in BP as a dependent variable and mm Hg (P = 0.00), respectively. changes over time in urinary sodium, potassium After 3 months of treatment a SBP of Ͻ160 mm Hg excretion and body weight as independent variables. Skewed variables were tested with the MannWhitney test. All tests were two-sided at the 0.05 in the drug group was excluded after a myocardial infarction. These patients' data were not used in the was attained by 45% (9/20) of the patients in the diet group against 75% (15/20) in the drug group. A DBP of Ͻ95 mm Hg was attained by 50% (10/20) of the patients in the diet group against 85% (17/20) in the chlorthalidone group (data not shown). The mean change of SBP after 3 months as a percentage of baseline was −5% in the diet group and −9% in the chlorthalidone group (P = 0.03 between both groups) (data not shown). Corresponding values for DBP were −4% and −9% (P = 0.03 between both groups). Table 3 shows the mean values in body weight and 24-h urinary excretion of sodium, potassium, and creatinine at baseline and after 3 months. Mean body weight decreased by 2(2) kg (P = 0.00) in the diet group and by 1(2) kg (P = 0.00) in the chlorthalidone group. In both groups no statistically significant changes occurred in mean urinary sodium, potassium and creatinine excretion. Weight loss exceeding 5% was achieved in 17% of the diet group patients and in 10% of the drug group patients (data not shown in Table 3 ). The mean changes in body weight as a percentage of baseline value for both groups amounted −3% and −1% (P = 0.19). A sodium excretion below 100 mmol/24h after 3 months was found in 45% (9/20) of the patients in the diet group and in 25% (5/20) of the patients in the drug group. The mean change as percentage was 12% and −34%, respectively (P = 0.04 between both groups). However, chlorthalidone group (Figure 2b : 204%, 170% and 168%) changes over time in sodium output were −4% (P = 0.68). The within group changes also were 8%. not significant. Fifteen per cent of the patients on diet excreted more than 100 mmol potassium in the 24-h urine while none of the patients taking drugs did so. The Metabolic side effects mean change of urinary potassium excretion as a Data on metabolic side effects are shown in Table 4 . percentage of the baseline value for both groups was Patients in the diet group showed an average 12% and −1% (P = 0.29). improvement in fat spectrum and blood glucose Creatinine excretion also did not show significant concentration. The drug group showed a change in change between the diet and drug group: −5% and the opposite direction. Serum potassium decreased significantly in the chlorthalidone group. The average changes expressed as percentage of the baseline Table 3 Mean body weight and 24-h urinary excretion of sodium, value for triglycerides, total cholesterol and HDLpotassium and creatinine at baseline and at 3 months in diet cholesterol concentration in the diet and drug group were −5% and 37% (P = 0.00), −4% and 5% difficult. In the weight loss group, excluding one outlier who was taking a very low sodium diet at (P = 0.00), 2% and −3% (P = 0.62), respectively. For blood glucose these values were −2% and 3% the start (and who had a complete urine collection), mean sodium output decreased 34 mmol/24h. The (P = 0.11). The corresponding values for serum potassium were −2% and −11% (P = 0.00).
Compliance with the diet
question is to what extent this amount of sodium restriction contributed to the lowering of the BP in the diet group. In an earlier study we found a BP Correlation of variables reduction of systolic 3 mm Hg and diastolic 2 mm Hg in a group of middle-aged persons who In the diet group only the change in DBP was significantly correlated to weight loss during treatment reduced urinary sodium (without weight reduction) by 22 mmol/24h. 6 Midgley et al 7 estimated from (r = 0.50, P Ͻ 0.05).
trials in older patients that a reduction of 100 mmol/24h results in a decrease of the systolic Changes of parameters in the diet group: weight and diastolic BP by 6 and 2 mm Hg, respectively. losers vs non-weight losers
Considering these data, we may assume that the contribution of sodium restriction to the hypotensive In the diet group 14 patients lost weight and six did not. After 3 months the mean SBP was reduced by effect in our study was relatively small. Mean weight loss in the diet group amounted to 9(11) mm Hg (P = 0.01) in the weight loss and by 7(8) mm Hg (P = 0.08) in the non-weight loss group. For 2 kg and was associated with a fall in systolic and diastolic BP to a maximum of 8 and 4 mm Hg, DBP these values were 6(7) mm Hg (P = 0.01) and 0 mm Hg, respectively. Change in mean body weight respectively. In the weight loss group BP decreased even more: 9 and 7 mm Hg, respectively. A fall in in the weight loss group was −3(2) kg (P = 0.00) in the weight loss and 0 in the non-weight loss group.
BP after weight reduction has also been observed in several other diet intervention studies, although The mean changes as percentage of baseline value for both groups amounted to −4% and 0%, respectresults vary. In a Swedish study in a group of 31 obese persons (40-69 years, BMI Ͼ30), a mean ively. Change in mean urinary sodium excretion was −28(53) mmol/24h (P = 0.07) in the weight loss and weight reduction of 7 kg occurred after 3 months together with a BP reduction of 6/3 mm Hg. 8 How-13(48) mmol/24h (P = 0.53) in the non-weight loss group. The mean changes as percentage for both ever, 22 of these individuals had stopped their antihypertensive treatment shortly before the study, groups amounted 9% and 18%, respectively. Excluding one outlier in the weight loss group and while in our study none of the patients had previously used medication. More favourable results one in the non-weight loss group ( 
Discussion
patient selection, the number of patients treated previously, and the nature of the dietary advice. In all In both groups BP decreased significantly. Regression to the mean, in part, might have contribthe studies mentioned, most participants were severely overweight. [8] [9] [10] uted to these changes. However, during the run-in period, there was only a small decrease in DBP after Our study shows that even if elderly patients are not seriously overweight, a considerable BP the first 2 weeks. Moreover, during intervention, in both groups changes in mean 24-h BP agreed with reduction (maximum systolic 8 mm Hg and diastolic 4 mm Hg) is possible. the changes in the conventionally measured BP. Thus, if there was regression to the mean, this effect This study was not designed to evaluate the separate effects of sodium restriction and weight loss: probably would have been small. Because of the small number of patients involved both factors may have played a role. Nonetheless, our study demonstrates the strongest effect occurin our study, conclusions should be drawn with caution. Therefore, we also re-analysed the BP data after ring with weight loss. A decrease of calorie intake usually will also result in a decrease in sodium the exclusion of the outliers in urinary sodium excretion. However, the difference between the two intake, because the sodium density per energy unit in food is fairly constant. This is in line with our groups in mean BP response did not change, nor did the difference in percentage of patients who became finding that in the weight loss group mean sodium output was more reduced. Therefore, in clinical normotensive between the two groups.
Measurements of urinary creatinine excretion practice, we think it seems more efficient to recommend the weight loss strategy as first approach. indicated that the patients had collected urine as instructed. In our study 3 months of dietary advice
In our study dietary measures were responsible for a fall back to normal systolic in 45% of the led to a reduction of only 15 mmol sodium/24h on average. Fifty-five per cent of the patients in the diet patients, and to normal diastolic BP in 50% of the patients. Treatment with a low dose diuretic (25 mg group did not attain the WHO guideline of 100 mmol sodium/24 h. However, baseline levels of chlorthalidone/day), arrived at a 75% normal systolic and 85% normal diastolic BP. mean sodium excretion at the start were already low, so further improvement might have been more
It has to be borne in mind, however, that the diet group had positive changes of lipid concentrations, the other hand, sodium reduction is achieved better by collective measures. Dietary intervention in which were absent or even negative in the drug group. We found a small improvement of serum patients with a BP exceeding 180 mm Hg systolic and 100 mm Hg diastolic appears not to be a lipid concentration in the diet group, while the opposite occurred in the chlorthalidone group. The question of or/or, but and/and. glucose concentration showed a similar trend. The same holds true for serum potassium, which clearly
